Alpha- Antitrypsin Deficiency Treatment Market

List of Tables
Table 1. Alpha- Antitrypsin Deficiency Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Alpha- Antitrypsin Deficiency Treatment Market Trends
Table 3. Alpha- Antitrypsin Deficiency Treatment Market Drivers
Table 4. Alpha- Antitrypsin Deficiency Treatment Market Challenges
Table 5. Alpha- Antitrypsin Deficiency Treatment Market Restraints
Table 6. Global Alpha- Antitrypsin Deficiency Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Alpha- Antitrypsin Deficiency Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Alpha- Antitrypsin Deficiency Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Alpha- Antitrypsin Deficiency Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Alpha- Antitrypsin Deficiency Treatment Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Alpha- Antitrypsin Deficiency Treatment Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Alpha- Antitrypsin Deficiency Treatment Revenue Share by Player, 2017-2022
Table 13. Global Alpha- Antitrypsin Deficiency Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Alpha- Antitrypsin Deficiency Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha- Antitrypsin Deficiency Treatment as of 2021)
Table 15. Top Players of Alpha- Antitrypsin Deficiency Treatment in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Alpha- Antitrypsin Deficiency Treatment Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Alpha- Antitrypsin Deficiency Treatment Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Alpha- Antitrypsin Deficiency Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Alpha- Antitrypsin Deficiency Treatment Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Alpha- Antitrypsin Deficiency Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Alpha- Antitrypsin Deficiency Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Alpha- Antitrypsin Deficiency Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Alpha- Antitrypsin Deficiency Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Alpha- Antitrypsin Deficiency Treatment Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Alpha- Antitrypsin Deficiency Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Alpha- Antitrypsin Deficiency Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Alpha- Antitrypsin Deficiency Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Adverum Biotechnologies, Inc. Company Details
Table 31. Adverum Biotechnologies, Inc. Business Overview
Table 32. Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 33. Adverum Biotechnologies, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 34. Adverum Biotechnologies, Inc. Recent Development
Table 35. Alnylam Pharmaceuticals, Inc. Company Details
Table 36. Alnylam Pharmaceuticals, Inc. Business Overview
Table 37. Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 38. Alnylam Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 39. Alnylam Pharmaceuticals, Inc. Recent Development
Table 40. Applied Genetic Technologies Corporation Company Details
Table 41. Applied Genetic Technologies Corporation Business Overview
Table 42. Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Product
Table 43. Applied Genetic Technologies Corporation Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 44. Applied Genetic Technologies Corporation Recent Development
Table 45. Arrowhead Pharmaceuticals, Inc. Company Details
Table 46. Arrowhead Pharmaceuticals, Inc. Business Overview
Table 47. Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 48. Arrowhead Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 49. Arrowhead Pharmaceuticals, Inc. Recent Development
Table 50. Carolus Therapeutics, Inc. Company Details
Table 51. Carolus Therapeutics, Inc. Business Overview
Table 52. Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 53. Carolus Therapeutics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 54. Carolus Therapeutics, Inc. Recent Development
Table 55. Cevec Pharmaceuticals GmbH Company Details
Table 56. Cevec Pharmaceuticals GmbH Business Overview
Table 57. Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Product
Table 58. Cevec Pharmaceuticals GmbH Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 59. Cevec Pharmaceuticals GmbH Recent Development
Table 60. Dicerna Pharmaceuticals, Inc. Company Details
Table 61. Dicerna Pharmaceuticals, Inc. Business Overview
Table 62. Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 63. Dicerna Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 64. Dicerna Pharmaceuticals, Inc. Recent Development
Table 65. Digna Biotech, S.L. Company Details
Table 66. Digna Biotech, S.L. Business Overview
Table 67. Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Product
Table 68. Digna Biotech, S.L. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 69. Digna Biotech, S.L. Recent Development
Table 70. Editas Medicine, Inc. Company Details
Table 71. Editas Medicine, Inc. Business Overview
Table 72. Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 73. Editas Medicine, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 74. Editas Medicine, Inc. Recent Development
Table 75. Grifols, S.A. Company Details
Table 76. Grifols, S.A. Business Overview
Table 77. Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Product
Table 78. Grifols, S.A. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 79. Grifols, S.A. Recent Development
Table 80. Inhibrx Company Details
Table 81. Inhibrx Business Overview
Table 82. Inhibrx Alpha- Antitrypsin Deficiency Treatment Product
Table 83. Inhibrx Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 84. Inhibrx Recent Development
Table 85. Intellia Therapeutics, Inc. Company Details
Table 86. Intellia Therapeutics, Inc. Business Overview
Table 87. Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 88. Intellia Therapeutics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 89. Intellia Therapeutics, Inc. Recent Development
Table 90. International Stem Cell Corporation Company Details
Table 91. International Stem Cell Corporation Business Overview
Table 92. International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Product
Table 93. International Stem Cell Corporation Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 94. International Stem Cell Corporation Recent Development
Table 95. Ionis Pharmaceuticals, Inc. Company Details
Table 96. Ionis Pharmaceuticals, Inc. Business Overview
Table 97. Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 98. Ionis Pharmaceuticals, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 99. Ionis Pharmaceuticals, Inc. Recent Development
Table 100. Kamada Ltd. Company Details
Table 101. Kamada Ltd. Business Overview
Table 102. Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Product
Table 103. Kamada Ltd. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 104. Kamada Ltd. Recent Development
Table 105. Polyphor Ltd. Company Details
Table 106. Polyphor Ltd. Business Overview
Table 107. Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Product
Table 108. Polyphor Ltd. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 109. Polyphor Ltd. Recent Development
Table 110. ProMetic Life Sciences Inc. Company Details
Table 111. ProMetic Life Sciences Inc. Business Overview
Table 112. ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 113. ProMetic Life Sciences Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 114. ProMetic Life Sciences Inc. Recent Development
Table 115. rEVO Biologics, Inc. Company Details
Table 116. rEVO Biologics, Inc. Business Overview
Table 117. rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 118. rEVO Biologics, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 119. rEVO Biologics, Inc. Recent Development
Table 120. Sangamo BioSciences, Inc. Company Details
Table 121. Sangamo BioSciences, Inc. Business Overview
Table 122. Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Product
Table 123. Sangamo BioSciences, Inc. Revenue in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022) & (US$ Million)
Table 124. Sangamo BioSciences, Inc. Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Alpha- Antitrypsin Deficiency Treatment Product Picture
Figure 2. Global Alpha- Antitrypsin Deficiency Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Alpha- Antitrypsin Deficiency Treatment Market Size 2017-2028 (US$ Million)
Figure 4. United States Alpha- Antitrypsin Deficiency Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Alpha- Antitrypsin Deficiency Treatment Market Size 2017-2028 (US$ Million)
Figure 6. United States Alpha- Antitrypsin Deficiency Treatment Market Share in Global 2017-2028
Figure 7. Alpha- Antitrypsin Deficiency Treatment Report Years Considered
Figure 8. Product Picture of CT-2009
Figure 9. Product Picture of POL-6014
Figure 10. Product Picture of ARO-AAT
Figure 11. Product Picture of ALNAAT-02
Figure 12. Product Picture of Others
Figure 13. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Type in 2022 & 2028
Figure 14. Global Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2017-2028) & (US$ Million)
Figure 15. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Type (2017-2028)
Figure 16. United States Alpha- Antitrypsin Deficiency Treatment Market Share by Type in 2022 & 2028
Figure 17. United States Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2017-2028) & (US$ Million)
Figure 18. United States Alpha- Antitrypsin Deficiency Treatment Market Share by Type (2017-2028)
Figure 19. Product Picture of Clinic
Figure 20. Product Picture of Hospital
Figure 21. Product Picture of Others
Figure 22. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Application in 2022 & 2028
Figure 23. Global Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2017-2028) & (US$ Million)
Figure 24. Global Alpha- Antitrypsin Deficiency Treatment Market Share by Application (2017-2028)
Figure 25. United States Alpha- Antitrypsin Deficiency Treatment Market Share by Application in 2022 & 2028
Figure 26. United States Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2017-2028) & (US$ Million)
Figure 27. United States Alpha- Antitrypsin Deficiency Treatment Market Share by Application (2017-2028)
Figure 28. North America Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. U.S. Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Canada Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. Europe Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 32. Germany Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. France Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. U.K. Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Italy Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Russia Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Asia-Pacific Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 38. China Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Japan Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. South Korea Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. India Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Australia Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Taiwan Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Indonesia Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Thailand Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Malaysia Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Philippines Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Latin America Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 49. Mexico Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Brazil Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Argentina Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 53. Turkey Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. U.A.E Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 56. Adverum Biotechnologies, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 57. Alnylam Pharmaceuticals, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 58. Applied Genetic Technologies Corporation Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 59. Arrowhead Pharmaceuticals, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 60. Carolus Therapeutics, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 61. Cevec Pharmaceuticals GmbH Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 62. Dicerna Pharmaceuticals, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 63. Digna Biotech, S.L. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 64. Editas Medicine, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 65. Grifols, S.A. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 66. Inhibrx Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 67. Intellia Therapeutics, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 68. International Stem Cell Corporation Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 69. Ionis Pharmaceuticals, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 70. Kamada Ltd. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 71. Polyphor Ltd. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 72. ProMetic Life Sciences Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 73. rEVO Biologics, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 74. Sangamo BioSciences, Inc. Revenue Growth Rate in Alpha- Antitrypsin Deficiency Treatment Business (2017-2022)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed